Back
NLS Pharmaceutics Stock Price Chart

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Sell
30
NLSP
NLS Pharmaceutics
Last Price:
$1.49
Seasonality Move:
-40.44%
7 Day Trial
ALL ACCESS PASS
$
7

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
NLS Pharmaceutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.5 | Buy |
20-day SMA: | 1.55 | Sell |
50-day SMA: | 1.84 | Sell |
200-day SMA: | 4.36 | Sell |
8-day EMA: | 1.51 | Buy |
20-day EMA: | 1.59 | Sell |
50-day EMA: | 1.86 | Sell |
200-day EMA: | 5.1 | Sell |
NLS Pharmaceutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 44.66 | Sell |
Chaikin Money Flow: | 27244 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.47 - 1.73) | Sell |
Bollinger Bands (100): | (1.54 - 3.04) | Sell |
NLS Pharmaceutics Technical Analysis
Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for NLS Pharmaceutics Stock
Is NLS Pharmaceutics Stock a Buy?
-
NLS Pharmaceutics share price is 1.54 while NLSP 8-day simple moving average is 1.50, which is a Buy signal.
-
The stock price of NLSP is 1.54 while NLS Pharmaceutics 20-day SMA is 1.55, which makes it a Sell.
-
NLS Pharmaceutics 50-day simple moving average is 1.84 while NLSP share price is 1.54, making it a Sell technically.
-
NLSP stock price is 1.54 and NLS Pharmaceutics 200-day simple moving average is 4.36, creating a Sell signal.
NLSP Technical Analysis vs Fundamental Analysis
Sell
30
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy or a Sell?
-
NLS Pharmaceutics stock is rated a SellThe current NLS Pharmaceutics [NLSP] share price is $1.54. The Score for NLSP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
NLS Pharmaceutics Stock Info
Market Cap:
5.9M
Price in USD:
1.54
Share Volume:
38.2K
NLS Pharmaceutics 52-Week Range
52-Week High:
18.39
52-Week Low:
1.30
Sell
30
NLS Pharmaceutics (NLSP)
is a Sell
NLS Pharmaceutics Share Price Forecast
-
What is the NLS Pharmaceutics stock price today?The NLS Pharmaceutics stock price is 1.54 USD today.
-
Will NLSP stock go up or go down?NLS Pharmaceutics> share price is forecast to RISE/FALL based on technical indicators
-
Is NLS Pharmaceutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NLS Pharmaceutics is overvalued.
Is NLS Pharmaceutics Stock a Buy?
-
NLS Pharmaceutics share price is 1.54 while NLSP 8-day exponential moving average is 1.51, which is a Buy signal.
-
The stock price of NLSP is 1.54 while NLS Pharmaceutics 20-day EMA is 1.59, which makes it a Sell.
-
NLS Pharmaceutics 50-day exponential moving average is 1.86 while NLSP share price is 1.54, making it a Sell technically.
-
NLSP stock price is 1.54 and NLS Pharmaceutics 200-day simple moving average is 5.10, creating a Sell signal.
Technical Analysis of NLS Pharmaceutics
Should I short NLS Pharmaceutics stock?
-
NLSP Moving Average Covergence Divergence (MACD) indicator is -0.11, suggesting NLS Pharmaceutics is a Sell
-
NLS Pharmaceutics Relative Strength Index (RSI) is 44.66, which suggest NLS Pharmaceutics is oversold
-
The Bollinger Bands (25) for NLS Pharmaceutics is (1.47 - 1.73), which suggest NLS Pharmaceutics is a Sell
-
The Bollinger Bands (100) for NLS Pharmaceutics is (1.54 - 3.04), which suggest NLS Pharmaceutics is a Sell
* NLS Pharmaceutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.